oral glp-1 agonist approved GLP-1: A Needle-Free Solution for Weight Loss GLP-1 Drug Savings: A Complete
Description
Pramlintide is an amylin analogue licensed for type 1 diabetes in the US but currently very few people are treated with it [4], and the risk of severe hypoglycaemia remains a barrier to its approval in the UK and Europe [5]
While targeted lifestyle changes can help to mitigate this side effect, newer drugs being developed in this space are aiming to preserve lean body mass
The aim of this article is to explore their clinical rationale, assess where they fit in the current guideline approach and identify which patients may derive benefit from their use
It is essential to understand that GLP-1 medications are not standalone solutions, and their effectiveness varies individually
